cangrelor
Ligand Summary
Cangrelor is a direct P2Y12 platelet receptor inhibitor that blocks ADP-induced platelet activation and aggregation. Cangrelor binds selectively and reversibly to the P2Y12 receptor to prevent further signaling and platelet activation.
UNII: 6AQ1Y404U7
PubChem: 9854012
PubChem: 11954340
Guide to Pharmacology: 1776
ChEMBL: CHEMBL334966
ChEMBL: CHEMBL1097279
DrugCentral: 5006
LyCHI: 2PP7NP1N8QA6
Target Activities
12 Activities
Items per page:
10
1 – 10 of 12
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
- | ||||||
IC50 | ||||||
- | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||